Target intelligence / Profile preview

Reactive oxygen species (ROS) regulatory pathways (ROS regulatory pathways)

Target
ROS regulatory pathways
Molecular classification
Enzyme, Transcription factor, Signaling pathway, Other
01

Overview

Reactive oxygen species (ROS) regulatory pathways consist of an integrated network of enzymes and signaling molecules that maintain cellular redox balance. Key components include antioxidant enzymes like superoxide dismutase, catalase, and glutathione peroxidase, which neutralize reactive molecules, as well as the Nrf2-Keap1 signaling axis that regulates the expression of cytoprotective genes (Source: PubMed, PMID: 30116495). While physiological levels of ROS are essential for signal transduction and immune function, excessive ROS production leads to oxidative stress, causing damage to DNA, proteins, and lipids (Source: NIH, National Cancer Institute). This imbalance is a critical driver in the pathogenesis of cancer, neurodegenerative diseases like Alzheimer's, and cardiovascular conditions (Source: PubMed, PMID: 24591304). Therapeutic interventions target these pathways either by enhancing antioxidant capacity to prevent tissue damage or by inducing ROS to trigger apoptosis in malignant cells (Source: Nature Reviews Drug Discovery). However, the complexity of redox biology poses significant challenges, as non-specific modulation can interfere with vital cellular signaling or inadvertently support tumor progression (Source: PubMed, PMID: 26845188).

Other names
Redox signaling pathwaysAntioxidant defense systemOxidative stress regulatory networkCellular redox homeostasis
02

Mechanism of action

The primary mechanisms of action involve the induction of endogenous antioxidant enzymes through the Nrf2-ARE signaling axis, direct chemical neutralization of free radicals by scavenging agents, or the inhibition of enzymatic sources of ROS such as NADPH oxidases (NOX) and xanthine oxidase (Source: PubMed, PMID: 28853742).

03

Biological functions

Redox homeostasisSignal transductionApoptosisCell proliferationImmune response
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseMetabolic disorder
05

Safety considerations

Antioxidant paradox (interference with essential ROS signaling)Potential to promote survival of existing cancer cellsLack of tissue specificitySystemic toxicity from disrupting redox-sensitive physiological processes
06

Interacting drugs

N-acetylcysteine

5 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Glutathione/Glutathione disulfide (GSH/GSSG) ratioProtein carbonylsF2-isoprostanes

Beyond the preview

Go deeper on Reactive oxygen species (ROS) regulatory pathways (ROS regulatory pathways).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species (ROS) regulatory pathways (ROS regulatory pathways).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call